| A | B |
| Dopamine | neurotransmitter involved in behavior |
| GABA | neurotransmitter that inhibits nerve conduction |
| MAOI | Monoamine oxidase inhibitors |
| Serotonin | neurotransmitter involved in behavior |
| SSRI | Selective serotonin reuptake inhibitors |
| Anti-anxiety drugs | Benzodiazepines, Phenothiazines, Azapirones |
| Antidepressants | Tricyclics, MAOI, SSRI |
| Reconcile, Clomicalm, | only drugs FDA approved for separation anxiety in dogs |
| Anipryl | FDA approved drug for canine cognitice dysfunction |
| Anticonvulsants | medications used to treat seizures |
| Convulsions | Seizures that manifest as spastic muscle movement due to stimulation of motor nerves in brain or spinal cord |
| Epilepsy | Recurrent seizures |
| Hepatotoxicity | damaging/toxic to the liver |
| Idiopathic | cause is unknown |
| Miosis | pupil constriction |
| Mydriasis | pupil dilation |
| Seizures | Altered brain function with loss of consciousness, muscle tone or movement, altered sensations & other neurologic changes |
| Status epilepticus | State of being in seizure activity, usually for prolonged time |
| Tolerance | enzymes induce for metabolism, drug is metabolized quicker; therefore, dose needs to be increased which induce more enzymes, etc. |
| Ataxia | lack of coordination of muscle movements |